PlainRecalls
FDA Drug Low Class III Terminated

Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540

Reported: July 12, 2017 Initiated: June 16, 2017 #D-0943-2017

Product Description

Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540

Reason for Recall

Cross Contamination With Other Product: Imipramine

Details

Recalling Firm
Sandoz Incorporated
Units Affected
38,234 bottles
Distribution
Product was distributed throughout the United States
Location
Broomfield, CO

Frequently Asked Questions

What product was recalled?
Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540. Recalled by Sandoz Incorporated. Units affected: 38,234 bottles.
Why was this product recalled?
Cross Contamination With Other Product: Imipramine
Which agency issued this recall?
This recall was issued by the FDA Drug on July 12, 2017. Severity: Low. Recall number: D-0943-2017.